Generic Name: Bempedoic acid for High Cholesterol, Familial Heterozygous ()
Bempedoic acid for High Cholesterol, Familial Heterozygous Reviews
"After coronary angioplasty with stent implantation into my LAD due to >99% blockage, I was put on bempedoic acid in addition to "background therapy" with atorvastatin and ezetimibe. I am 44 and have a heterozygous LDL receptor mutation. LDL was 260 mg/dl (6.7 mmol/l) without medication, and 160 mg/dl (4.1 mmol/l) with atorvastatin/ezetimibe 20/10 mg. Addition of bempedoic acid brought LDL down to 110 mg/dl (2.8 mmol/l) without noticeable side effects. However, uric acid levels skyrocketed which is a known side effect. I stopped taking bempedoic acid and am now on inclisiran (not yet available in the US) which has brought down my LDL to 60 mg/dl (1.5 mmol/l) within one week. Effective medication, but check your uric acid levels regularly since this drug can cause gout!"
"Thankfully, of all the listed side effects, I haven't experienced any of them. I'm looking forward to my next labs and hopefully they'll be good."
More about bempedoic acid
- Check interactions
- Compare alternatives
- Reviews (7)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Drug class: miscellaneous antihyperlipidemic agents
- Breastfeeding
- En español
Patient resources
- Bempedoic acid drug information
Other brands
Nexletol
Professional resources
- Bempedoic Acid monograph
Other brands
Nexletol
Related treatment guides
- High Cholesterol, Familial Heterozygous
- Cardiovascular Risk Reduction
- High Cholesterol
